Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 607

1.

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.

Bernardino JI, Mocroft A, Wallet C, de Wit S, Katlama C, Reiss P, Mallon PW, Richert L, Molina JM, Knobel H, Morlat P, Babiker A, Pozniac A, Raffi F, Arribas JR; NEAT001/ANRS143 Trial Study Group.

PLoS One. 2019 Jan 28;14(1):e0209911. doi: 10.1371/journal.pone.0209911. eCollection 2019.

2.

Gallium - a versatile element for tuning the photoluminescence properties of InP quantum dots.

Wegner KD, Pouget S, Ling WL, Carrière M, Reiss P.

Chem Commun (Camb). 2019 Jan 31;55(11):1663-1666. doi: 10.1039/c8cc09740b.

PMID:
30657488
3.

Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM.

Newsum AM, Kooij KW, Boyd A, Smit C, Wit FWNM, van der Meer JTM, Prins M, Reiss P, van der Valk M; MOSAIC study group, ATHENA observational HIV cohort and NVHB-SHM hepatitis working group.

AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002138. [Epub ahead of print]

PMID:
30649050
4.

Compliance with laboratory monitoring guidelines in outpatient HIV care: a qualitative study in the Netherlands.

Toxopeus DCM, Pell CL, Westrhenen NB, Smit C, Wit FWNM, Ondoa P, Reiss P, Boender TS.

AIDS Care. 2019 Jan 2:1-8. doi: 10.1080/09540121.2018.1563280. [Epub ahead of print]

PMID:
30602294
5.

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.

Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, Thiebaut R, Guest J, Gill J, Crane H, Dias Lima V, dʼArminio Monforte A, Sterling TR, Miro J, Moreno S, Stephan C, Smith C, Tate J, Shepherd L, Saag M, Rieger A, Gillor D, Cavassini M, Montero M, Ingle SM, Reiss P, Costagliola D, Wit FWNM, Sterne J, de Wolf F, Geskus R; Antiretroviral Therapy Cohort Collaboration (ART-CC).

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):292-300. doi: 10.1097/QAI.0000000000001913.

PMID:
30531492
6.

Patterns of Co-occurring Comorbidities in People Living With HIV.

De Francesco D, Verboeket SO, Underwood J, Bagkeris E, Wit FW, Mallon PWG, Winston A, Reiss P, Sabin CA; Pharmacokinetic and Clinical Observations in PeoPle Over fiftY (POPPY) study and the AGEhIV Cohort Study.

Open Forum Infect Dis. 2018 Oct 24;5(11):ofy272. doi: 10.1093/ofid/ofy272. eCollection 2018 Nov.

7.

Reduced Forced Vital Capacity among HIV-infected middle-aged individuals.

Verboeket SO, Wit FW, Kirk GD, Drummond MB, van Steenwijk RP, van Zoest RA, Nellen JF, van der Loeff MFS, Reiss P; AGEh IV study group.

J Infect Dis. 2018 Nov 12. doi: 10.1093/infdis/jiy653. [Epub ahead of print]

PMID:
30418599
8.

Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.

Lieveld FI, Smit C, Richter C, van Erpecum KJ, Spanier BWM, Gisolf EH, Vrolijk JM, Siersema PD, Hoepelman AIM, Reiss P, Arends JE.

Liver Int. 2018 Nov 9. doi: 10.1111/liv.14000. [Epub ahead of print]

PMID:
30411848
9.

Do people living with HIV experience greater age advancement than their HIV-negative counterparts?

De Francesco D, Wit FW, Bürkle A, Oehlke S, Kootstra NA, Winston A, Franceschi C, Garagnani P, Pirazzini C, Libert C, Grune T, Weber D, Jansen EHJM, Sabin CA, Reiss P; the Co-morBidity in Relation to AIDS (COBRA) Collaboration.

AIDS. 2019 Feb 1;33(2):259-268. doi: 10.1097/QAD.0000000000002063.

10.

AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile.

Boender TS, Smit C, Sighem AV, Bezemer D, Ester CJ, Zaheri S, Wit FWNM, Reiss P; ATHENA national observational HIV cohort.

BMJ Open. 2018 Sep 24;8(9):e022516. doi: 10.1136/bmjopen-2018-022516.

11.

A light-triggered transmembrane porin.

Kahlstatt J, Reiß P, Halbritter T, Essen LO, Koert U, Heckel A.

Chem Commun (Camb). 2018 Aug 23;54(69):9623-9626. doi: 10.1039/c8cc05221b.

PMID:
30095845
12.

[The older HIV patient in the Netherlands].

Verheij E, van Zoest RA, van der Valk M, Wit FW, Reiss P.

Ned Tijdschr Geneeskd. 2018 Jul 5;162. pii: D2886. Dutch.

PMID:
30040311
13.

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Hatleberg CI, Ryom L, d'Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr W, Phillips A, de Wit S, Dabis F, Weber R, Law M, Lundgren JD, Sabin C; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

HIV Med. 2018 Oct;19(9):605-618. doi: 10.1111/hiv.12639. Epub 2018 Jul 18.

PMID:
30019813
14.

Activation Energy of Organic Cation Rotation in CH3NH3PbI3 and CD3NH3PbI3: Quasi-Elastic Neutron Scattering Measurements and First-Principles Analysis Including Nuclear Quantum Effects.

Li J, Bouchard M, Reiss P, Aldakov D, Pouget S, Demadrille R, Aumaitre C, Frick B, Djurado D, Rossi M, Rinke P.

J Phys Chem Lett. 2018 Jul 19;9(14):3969-3977. doi: 10.1021/acs.jpclett.8b01321. Epub 2018 Jul 5.

15.

Circular Dichroism in Fluorescence Emission Following the C 1s→π* Excitation and Resonant Auger Decay of Carbon Monoxide.

Pitzer M, Schmidt P, Ozga C, Hans A, Reiß P, Petrov ID, Artemyev AN, Ehresmann A, Knie A, Demekhin PV.

Molecules. 2018 Jun 26;23(7). pii: E1534. doi: 10.3390/molecules23071534.

16.

Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.

Shepherd L, Ryom L, Law M, Petoumenos K, Hatleberg CI, d'Arminio Monforte A, Sabin C, Bower M, Bonnet F, Reiss P, de Wit S, Pradier C, Weber R, El-Sadr W, Lundgren J, Mocroft A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

Clin Infect Dis. 2019 Feb 1;68(4):650-657. doi: 10.1093/cid/ciy508.

PMID:
29912335
17.

Clinical research cerebral MRI findings in HIV-positive subjects and appropriate controls.

Chhabra S, Underwood J, Cole JH, Caan M, Waldman A, Reiss P, Sabin CA, Sharp DJ, Winston A; CoBRA collaboration.

AIDS. 2018 Sep 10;32(14):2077-2081. doi: 10.1097/QAD.0000000000001910.

PMID:
29912060
18.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.

Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Rehm CA, Pozniak A, Montaner JSG, Lane HC, Larder BA; RDI Data and Study Group .

J Antimicrob Chemother. 2018 Aug 1;73(8):2186-2196. doi: 10.1093/jac/dky179.

PMID:
29889249
19.

Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver.

Wymant C, Blanquart F, Golubchik T, Gall A, Bakker M, Bezemer D, Croucher NJ, Hall M, Hillebregt M, Ong SH, Ratmann O, Albert J, Bannert N, Fellay J, Fransen K, Gourlay A, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Cornelissen M, Kellam P, Reiss P, Fraser C; BEEHIVE Collaboration.

Virus Evol. 2018 May 18;4(1):vey007. doi: 10.1093/ve/vey007. eCollection 2018 Jan.

20.

Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio.

Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, d'Arminio Monforte A, Smith C, Cavassini M, Saag M, Castilho JL, Sterne JAC.

AIDS. 2018 Jun 19;32(10):1361-1367. doi: 10.1097/QAD.0000000000001848.

21.

Associations between serum albumin and serious non-AIDS events among people living with HIV.

Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P, Weber R, Pradier C, De Wit S, Law M, d'Arminio Monforte A, Lundgren J, Mocroft A, Phillips AN, Sabin CA; D:A:D Study Group.

AIDS. 2018 Aug 24;32(13):1837-1848. doi: 10.1097/QAD.0000000000001900.

22.

Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort Analysis.

Achhra AC, Sabin C, Ryom L, Hatleberg C, Antonella dʼAminio M, de Wit S, Phillips A, Pradier C, Weber R, Reiss P, El-Sadr W, Bonnet F, Mocroft A, Lundgren J, Law MG; D:A:D Study Group.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):579-588. doi: 10.1097/QAI.0000000000001722.

PMID:
29771788
23.

HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy.

Dijkstra M, van Lunsen RHW, Kooij KW, Davidovich U, van Zoest RA, Wit FWMN, Prins M, Reiss P, Schim van der Loeff MF; AGEhIV Cohort Study Group.

AIDS. 2018 Jun 1;32(9):1137-1146. doi: 10.1097/QAD.0000000000001800.

PMID:
29746318
24.

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.

Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, Monforte AD, Smith C, Cavassini M, Saag M, Sterling TR, Sterne JAC.

AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001848. [Epub ahead of print]

PMID:
29734221
25.

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d' Arminio Monforte A, De Wit S, Dabis F, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.

Lancet HIV. 2018 Jun;5(6):e291-e300. doi: 10.1016/S2352-3018(18)30043-2. Epub 2018 May 3.

PMID:
29731407
26.

The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics.

De Francesco D, Wit FW, Cole JH, Kootstra NA, Winston A, Sabin CA, Underwood J, van Zoest RA, Schouten J, Kooij KW, Prins M, Guaraldi G, Caan MWA, Burger D, Franceschi C, Libert C, Bürkle A, Reiss P; COmorBidity in Relation to AIDS (COBRA) collaboration.

PLoS One. 2018 Mar 29;13(3):e0191791. doi: 10.1371/journal.pone.0191791. eCollection 2018.

27.

HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART.

Do TC, Kerr SJ, Avihingsanon A, Suksawek S, Klungkang S, Channgam T, Odermatt CC, Maek-A-Nantawat W, Ruxtungtham K, Ananworanich J, Valcour V, Reiss P, Wit FW.

J Virus Erad. 2018 Jan 1;4(1):41-47.

28.

Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.

Kroeze S, Ondoa P, Kityo CM, Siwale M, Akanmu S, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, Boender TS, de Pundert ME, Sigaloff KCE, Reiss P, Wit FWNM, Rinke de Wit TF, Hamers RL.

AIDS. 2018 May 15;32(8):1043-1051. doi: 10.1097/QAD.0000000000001801.

PMID:
29547445
29.

HIV-1 status is independently associated with decreased erectile function among middle-aged men who have sex with men in the era of cART.

Dijkstra M, Van Lunsen RHW, Kooij KW, Davidovich U, Van Zoest RA, Wit FWMN, Prins M, Reiss P, Loeff MFSV; AGEhIV Cohort Study Group.

AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001800. [Epub ahead of print]

PMID:
29547444
30.

Cross-sectional versus longitudinal designs for function estimation, with an application to cerebral cortex development.

Reiss PT.

Stat Med. 2018 May 20;37(11):1895-1909. doi: 10.1002/sim.7617. Epub 2018 Mar 15.

PMID:
29542142
31.

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.

Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d'Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25083.

32.

Comment.

Reiss PT, Goldsmith J.

J Am Stat Assoc. 2017;112(517):161-164. doi: 10.1080/01621459.2016.1270049. Epub 2017 May 3. No abstract available.

33.

Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.

Santos JR, Cozzi-Lepri A, Phillips A, De Wit S, Pedersen C, Reiss P, Blaxhult A, Lazzarin A, Sluzhynska M, Orkin C, Duvivier C, Bogner J, Gargalianos-Kakolyris P, Schmid P, Hassoun G, Khromova I, Beniowski M, Hadziosmanovic V, Sedlacek D, Paredes R, Lundgren JD; EuroSIDA study group.

HIV Med. 2018 May;19(5):324-338. doi: 10.1111/hiv.12581. Epub 2018 Feb 1.

PMID:
29388732
34.

Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.

Snijdewind IJM, Smit C, Godfried MH, Bakker R, Nellen JFJB, Jaddoe VWV, van Leeuwen E, Reiss P, Steegers EAP, van der Ende ME.

PLoS One. 2018 Jan 19;13(1):e0191389. doi: 10.1371/journal.pone.0191389. eCollection 2018.

35.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031.

36.

Reply to Moso et al.

Kooij KW, Vogt L, Reiss P.

J Infect Dis. 2018 Mar 5;217(6):1015-1016. doi: 10.1093/infdis/jix677. No abstract available.

PMID:
29309613
37.

No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project.

Cole JH, Caan MWA, Underwood J, De Francesco D, van Zoest RA, Wit FWNM, Mutsaerts HJMM, Leech R, Geurtsen GJ, Portegies P, Majoie CBLM, Schim van der Loeff MF, Sabin CA, Reiss P, Winston A, Sharp DJ; Comorbidity in Relations to AIDS (COBRA) Collaboration.

Clin Infect Dis. 2018 Jun 1;66(12):1899-1909. doi: 10.1093/cid/cix1124.

38.

Correction: Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts.

Cohen S, Innes S, Geelen SPM, Wells JCK, Smit C, Wolfs TFW, van Eck-Smit BLF, Kuijpers TW, Reiss P, Scherpbier HJ, Pajkrt D, Bunders MJ.

PLoS One. 2018 Jan 2;13(1):e0190726. doi: 10.1371/journal.pone.0190726. eCollection 2018.

39.

Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.

Shepherd L, Ryom L, Law M, Hatleberg CI, de Wit S, Monforte AD, Battegay M, Phillips A, Bonnet F, Reiss P, Pradier C, Grulich A, Sabin C, Lundgren J, Mocroft A.

J Natl Cancer Inst. 2018 Jun 1;110(6):598-607. doi: 10.1093/jnci/djx249.

PMID:
29267895
40.

Noncommunicable Diseases in People Living With HIV: Time for Integrated Care.

van der Valk M, Reiss P.

J Infect Dis. 2017 Dec 19;216(12):1481-1483. doi: 10.1093/infdis/jix525. No abstract available.

PMID:
29253145
41.

Penalized nonparametric scalar-on-function regression via principal coordinates.

Reiss PT, Miller DL, Wu PS, Hua WY.

J Comput Graph Stat. 2017;26(3):569-578. doi: 10.1080/10618600.2016.1217227. Epub 2016 Aug 2.

42.

Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity.

Soave A, Dahlem R, Pinnschmidt HO, Rink M, Langetepe J, Engel O, Kluth LA, Loechelt B, Reiss P, Ahyai SA, Fisch M.

Eur Urol. 2018 Jun;73(6):910-922. doi: 10.1016/j.eururo.2017.11.014. Epub 2017 Dec 1.

PMID:
29198583
43.

Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.

Smolders EJ, Smit C, de Kanter C, Dofferhoff A, Arends JE, Brinkman K, Rijnders B, van der Valk M, Reiss P, Burger DM; ATHENA National HIV Observational Cohort.

HIV Med. 2018 Mar;19(3):216-226. doi: 10.1111/hiv.12570. Epub 2017 Dec 1.

PMID:
29194939
44.

High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands.

Boerekamps A, Newsum AM, Smit C, Arends JE, Richter C, Reiss P, Rijnders BJA, Brinkman K, van der Valk M; NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort .

Clin Infect Dis. 2018 Apr 17;66(9):1352-1359. doi: 10.1093/cid/cix1004.

PMID:
29186365
45.

Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.

Lodi S, Günthard HF, Dunn D, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Schneider MP, Egger M, Glass TR, Reiss P, van Sighem A, Boender TS, Phillips AN, Porter K, Hawkins D, Moreno S, Monge S, Paraskevis D, Simeon M, Vourli G, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.

AIDS. 2018 Jan 28;32(3):327-335. doi: 10.1097/QAD.0000000000001692.

46.

How to build an allogeneic hematopoietic cell transplant unit in 2016: Proposal for a practical framework.

Crysandt M, Yakoub-Agha I, Reiß P, Theisen S, Silling G, Glatte P, Nelles E, Lemmen S, Brümmendorf TH, Kontny U, Jost E.

Curr Res Transl Med. 2017 Nov;65(4):149-154. doi: 10.1016/j.retram.2017.10.003. Epub 2017 Nov 6.

PMID:
29122584
47.

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.

Boyd MA, Mocroft A, Ryom L, Monforte AD, Sabin C, El-Sadr WM, Hatleberg CI, De Wit S, Weber R, Fontas E, Phillips A, Bonnet F, Reiss P, Lundgren J, Law M.

PLoS Med. 2017 Nov 7;14(11):e1002424. doi: 10.1371/journal.pmed.1002424. eCollection 2017 Nov.

48.

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD; EuroSIDA Study.

AIDS. 2018 Jan 14;32(2):205-215. doi: 10.1097/QAD.0000000000001684.

PMID:
29112060
49.

Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection.

Young J, Smith C, Teira R, Reiss P, Jarrín Vera I, Crane H, Miro JM, D'Arminio Monforte A, Saag M, Zangerle R, Bucher HC; Antiretroviral Therapy Cohort Collaboration (ART-CC).

HIV Med. 2018 Feb;19(2):132-142. doi: 10.1111/hiv.12562. Epub 2017 Nov 6.

PMID:
29110395
50.

Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers.

van Zoest RA, Underwood J, De Francesco D, Sabin CA, Cole JH, Wit FW, Caan MWA, Kootstra NA, Fuchs D, Zetterberg H, Majoie CBLM, Portegies P, Winston A, Sharp DJ, Gisslén M, Reiss P; Comorbidity in Relation to AIDS (COBRA) Collaboration .

J Infect Dis. 2017 Dec 27;217(1):69-81. doi: 10.1093/infdis/jix553.

Supplemental Content

Support Center